Product Recalls in Colorado

Product recalls affecting Colorado — including food, drugs, consumer products, medical devices, and vehicles distributed to Colorado. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,724 recalls have been distributed to Colorado in the last 12 months.

51,434 total recalls
2,724 in last 12 months

Showing 901920 of 13,494 recalls

DrugOctober 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 15 mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Morphine Sulfate Extended-Release Tablets 30 mg Recalled by Dr. Reddy's...

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules Recalled by AvKARE Due to Labeling: Label Mix-Up

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 18, 2024· AvKARE

Recalled Item: Sunitinib Malate Capsules Recalled by AvKARE Due to Labeling: Label Mix-Up

The Issue: Labeling: Label Mix-Up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 17, 2024· Keystone Industries

Recalled Item: Perio Maintenance Rinse 0.63% Stannous Fluoride Concentrated Solution...

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 15, 2024· Akron Pharma, Inc.

Recalled Item: OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 11, 2024· Padagis US LLC

Recalled Item: Triamcinolone Acetonide Cream USP Recalled by Padagis US LLC Due to...

The Issue: Subpotent and Superpotent Drug. Out of specification assay results recorded...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cinacalcet Tablets 30 mg Recalled by ACCORD HEALTHCARE, INC. Due to CGMP...

The Issue: CGMP Deviations: the presence of a nitrosamine impurity,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 10, 2024· Breckenridge Pharmaceutical, Inc

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 9, 2024· Dr. Reddy's Laboratories, Inc.

Recalled Item: Cinacalcet Tablets Recalled by Dr. Reddy's Laboratories, Inc. Due to CGMP...

The Issue: CGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 8, 2024· C & A Naturistics

Recalled Item: AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas Recalled by C & A...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 1, 2024· ACCORD HEALTHCARE, INC.

Recalled Item: Cisplatin Injection Recalled by ACCORD HEALTHCARE, INC. Due to Failed...

The Issue: Failed Impurities/Degradation Specifications.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 30, 2024· Staska Pharmaceuticals, Inc.

Recalled Item: Ascorbic Acid Inj. Solution Recalled by Staska Pharmaceuticals, Inc. Due to...

The Issue: Presence of Particulate Matter: Presence of glass particulates.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugSeptember 30, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Ciclopirox Gel 0.77% Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: Defective Container: Firm received complaints of broken tube at the seal.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Thiamine HCl 0.9% Sodium Chloride Injection USP Recalled by Fresenius Kabi...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugSeptember 25, 2024· Fresenius Kabi Compounding, LLC

Recalled Item: Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP Recalled...

The Issue: cGMP violations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund